TagsSKY0515

Tag: SKY0515

Healthcare

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Ravindra Soni - January 27, 2026 0

Healthcare

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Ravindra Soni - September 17, 2025 0

Entertainment

Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington's Disease

Ravindra Soni - October 23, 2023 0

Most Read

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

TukTuki streams ‘What Is Dyslexia’ film for Dyslexia Awareness Month

November 4, 2026

EDITOR PICKS

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

POPULAR POSTS

365squared unveils AI-based voice fraud platform 365callguard

November 4, 2026

Smiths Group to add 500 early careers roles globally over five years

November 4, 2026

ICICI Life Insurance launches BSE 500 Momentum Quality 50 Index Fund

November 4, 2026

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.